Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:49 pm Unchanged | 2024-12-31 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 6,800,000 6.750% | 0 (Unchanged) | Filing History |
| 2025-02-13 6:24 pm Sale | 2024-12-31 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 4,616,130 4.580% | -5,295,101 (-53.43%) | Filing History |
| 2024-11-14 4:52 pm Sale | 2024-09-30 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 6,800,000 6.770% | -2,964,000 (-30.36%) | Filing History |
| 2024-11-12 4:01 pm Sale | 2024-09-30 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 9,911,231 9.870% | -4,560,697 (-31.51%) | Filing History |
| 2024-11-12 2:33 pm Unchanged | 2024-09-30 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 5,882,361 5.850% | 0 (Unchanged) | Filing History |
| 2024-11-04 1:08 pm Unchanged | 2024-09-30 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 5,882,361 5.850% | 0 (Unchanged) | Filing History |
| 2024-11-04 12:11 pm Sale | 2024-09-30 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 5,882,361 5.850% | -1,161,788 (-16.49%) | Filing History |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | FibroGen, Inc. FGEN | BlackRock Inc. BLK | 2,409,650 2.400% | -4,795,650 (-66.56%) | Filing History |
| 2024-02-14 3:37 pm Purchase | 2023-12-31 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 9,764,000 9.930% | 9,764,000 (New Position) | Filing History |
| 2024-02-14 10:04 am Sale | 2023-12-31 | 13G | FibroGen, Inc. FGEN | Point72 Asset Management, L.P. | 1,643,844 1.700% | -4,637,801 (-73.83%) | Filing History |
| 2024-02-13 5:04 pm Sale | 2023-12-29 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 7,044,149 7.160% | -2,399,920 (-25.41%) | Filing History |
| 2024-02-12 4:01 pm Purchase | 2023-12-31 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 14,471,928 14.720% | 576,850 (+4.15%) | Filing History |
| 2024-01-26 4:23 pm Purchase | 2023-12-31 | 13G | FibroGen, Inc. FGEN | BlackRock Inc. BLK | 7,205,300 7.300% | 71,562 (+1.00%) | Filing History |
| 2023-07-19 4:47 pm Purchase | 2023-07-13 | 13G | FibroGen, Inc. FGEN | MILLENNIUM MANAGEMENT LLC | 4,587,813 4.700% | 4,587,813 (New Position) | Filing History |
| 2023-02-14 4:22 pm Purchase | 2022-12-31 | 13G | FibroGen, Inc. FGEN | Point72 Asset Management, L.P. | 6,281,645 6.700% | 1,615,538 (+34.62%) | Filing History |
| 2023-02-09 4:01 pm Purchase | 2022-12-31 | 13G | FibroGen, Inc. FGEN | PRIMECAP MANAGEMENT CO/CA/ | 13,895,078 14.790% | 905,955 (+6.97%) | Filing History |
| 2023-02-09 11:19 am Purchase | 2022-12-30 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 9,444,069 10.050% | 58,880 (+0.63%) | Filing History |
| 2023-02-08 10:05 am Sale | 2022-12-31 | 13G | FibroGen, Inc. FGEN | First Trust Portfolios L.P. | 2,975,653 3.170% | -2,341,960 (-44.04%) | Filing History |
| 2023-02-06 12:37 pm Purchase | 2022-12-31 | 13G | FibroGen, Inc. FGEN | BlackRock Inc. BLK | 7,133,738 7.600% | 488,196 (+7.35%) | Filing History |
| 2022-03-09 08:44 am Purchase | 2022-02-28 | 13G | FibroGen, Inc. FGEN | VANGUARD GROUP INC | 9,385,189 10.090% | 349,001 (+3.86%) | Filing History |